Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda

Abstract Anaemia has not been well characterised among HIV-infected children in sub-Saharan Africa. Baseline prevalence and cumulative incidence of anaemia (haemoglobin <110 g/L) were 91.7% and 100% and, for moderate anaemia (haemoglobin <90 g/L), were 35.1% and 58.4%, respectively, among 225 HIV-infected children followed from 9 to 36 months of age. Hospitalisation, suspected tuberculosis, malaria and height-for-age Z-score <-2 were significantly associated with moderate anaemia. Moderate anaemia and weight-for-height Z-score <-2 were associated with mortality. Anaemia is common and associated with increased mortality in HIV-infected children.

[1]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[2]  R. Semba,et al.  Iron supplementation during human immunodeficiency virus infection: a double-edged sword? , 2001, Medical hypotheses.

[3]  G. Gray,et al.  Pathogenesis of Anemia During Human Immunodeficiency Virus Infection , 2001, Journal of Investigative Medicine.

[4]  E. Pollitt The developmental and probabilistic nature of the functional consequences of iron-deficiency anemia in children. , 2001, The Journal of nutrition.

[5]  Z. Premji,et al.  An analysis of anemia and child mortality. , 2001, The Journal of nutrition.

[6]  M. Quigley,et al.  Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study , 2000, The Lancet.

[7]  P. Volberding,et al.  Consensus statement: anemia in HIV infection--current trends, treatment options, and practice strategies. Anemia in HIV Working Group. , 2000, Clinical therapeutics.

[8]  L. Mofenson,et al.  Advances and research directions in the prevention of mother-to-child HIV-1 transmission , 2000, The Lancet.

[9]  M. Parker,et al.  HIV and Infant Feeding. (World Health Organization, Joint United Nations Programme on HIV/AIDS (UNAIDS) and United Nations Children's Fund, 1998.) US $14.40. , 2000 .

[10]  G. Pescarmona,et al.  Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? , 1999, Cell biochemistry and function.

[11]  Dorothy Bray,et al.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.

[12]  R. Moore,et al.  Human immunodeficiency virus infection, anemia, and survival. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Diop,et al.  [Hematologic abnormalities and immunodepression in HIV/AIDS- related pulmonary tuberculosis]. , 1999, Bulletin de la Societe de pathologie exotique.

[14]  L. Sacks,et al.  Factors related to in-hospital deaths in patients with tuberculosis. , 1998, Archives of internal medicine.

[15]  W. Andiman,et al.  Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. , 1996, The Journal of pediatrics.

[16]  E. Weinberg,et al.  Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. , 1996, Infectious agents and disease.

[17]  L. Kalish,et al.  Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. , 1996, The Journal of pediatrics.

[18]  J. Adewuyi,et al.  Haematologic features of the human immunodeficiency virus (HIV) infection in Black children in Harare. , 1994, The Central African journal of medicine.

[19]  A. Rubinstein,et al.  Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. , 1990, The American journal of pediatric hematology/oncology.

[20]  H. Nell,et al.  The haematological and biochemical changes in severe pulmonary tuberculosis. , 1989, The Quarterly journal of medicine.

[21]  J. Phair,et al.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.

[22]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[23]  G. Cartwright,et al.  The anemia of infection. XIX. Studies on free erythrocyte coproporphyrin and protoporphyrin. , 1954, Blood.